People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Modifi Biosciences, Inc. | — | Biotechnology | Series A | $11.5M | $4.9M | 2022 |
Seth L. Herzon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Seth L. Herzon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin L. Rakin | 1 | 7 |
| Ranjit L. Bindra | 1 | 3 |
| Kat L. Kayser-Bricker | 1 | 1 |
| Lucas L. De Breed | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.